Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GB0139
GB0139
Galecto Drops Idiopathic Pulmonary Fibrosis Hopeful After Phase II Flop
BioSpace
Tue, 08/15/23 - 10:10 am
Galecto
clinical trials
GB0139
idiopathic pulmonary fibrosis
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward
Xconomy
Sun, 09/27/20 - 11:07 pm
Galecto Biotech
idiopathic pulmonary fibrosis
IPF
GB0139